207
Fig. 8.1 Identified limitations of classical drug therapy expected to be overcome by using nanostructured carriers
Fig. 8.2 Main properties of nanostructured carriers to overcome biological barriers for targeted
drug delivery
8 In Vitro Methodologies for Toxicological Assessment of Drug Delivery Nanocarriers